Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
42.76
+0.13 (0.30%)
At close: Feb 11, 2026, 4:00 PM EST
42.76
0.00 (0.00%)
After-hours: Feb 11, 2026, 4:40 PM EST
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $3.3 billion as of February 11, 2026. Its market cap has increased by 8.05% in one year.
Market Cap
3.30B
Enterprise Value
2.76B
1-Year Change
8.05%
Ranking
Category
Stock Price
$42.76
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $3.30B, an increase of 2,223.68%. That is a compound annual growth rate of 32.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.29B | -4.89% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 3.61B |
| Ligand Pharmaceuticals | 3.58B |
| Liquidia | 3.48B |
| Centessa Pharmaceuticals | 3.43B |
| Legend Biotech | 3.42B |
| Arcutis Biotherapeutics | 3.21B |
| Edgewise Therapeutics | 3.18B |
| Viking Therapeutics | 3.16B |